Stay current with the latest sickle cell research, regulatory updates, and guidelines.
To examine the prevalence of lapsed attendance (LA) among young children with sickle cell disease (SCD), identify factors statistically associated with gaps in SCD clinic attendance, and characterize caregiver-reported reasons...
To examine intrapersonal and environmental facilitators and barriers influencing dietary intake among adults living with sickle cell disease (SCD) using qualitative interviews within a mixed-methods study, and to better understand...
To evaluate the efficacy, safety, and optimal dosing of osivelotor, a sickle hemoglobin (HbS) polymerization inhibitor, in adults with sickle cell disease (SCD), and to assess the durability of response...
To describe a rare case of plastic bronchitis complicating acute chest syndrome (ACS) in a child with sickle cell disease (SCD) and highlight the importance of early recognition of this...
To characterize placental histopathology in the Townes humanized mouse model of sickle cell disease (SCD) and determine how closely the observed placental abnormalities resemble those reported in pregnancies affected by...
To evaluate whether red blood cell (RBC)-bound ADP-ribosylation factor-like protein 13b (ARL13b), a cilia-associated protein, is associated with future vaso-occlusive crises (VOC) and disease severity in sickle cell disease (SCD),...
To evaluate the criterion validity of the Functional Status Pain Assessment (FSPA), a 10-item functional assessment tool, by examining its relationship with pain intensity and hospital length of stay (LOS)...
To evaluate whether intravenous (IV) diphenhydramine use is associated with new-onset acute chest syndrome (ACS) among adults hospitalized for vaso-occlusive episodes (VOE), while adjusting for inpatient opioid exposure.
To describe the outcomes of a sustained, collaborative, long-term multidisciplinary health provider andcommunity advisory group focused on improving sickle cell disease (SCD) care, education, and research.
To investigate cerebral microvascular injury in a humanized mouse model of sickle cell disease (SCD) and examine the relationship between cerebral microhemorrhages (CMHs) and mast cells.